logo

Gastroenterology Research and Practice
Gastroenterology Research and Practice/2020/Article/Tab 1

Research Article

Gastrointestinal Bleeding due to Pancreatic Disease-Related Portal Hypertension

Table 1

Characteristics of the patients with left-sided portal hypertension.
Variables 1 (TL) 2 (YC) 3 (WZ) 4 (JH) 5 (HW)
性别 男性 男性 男性 男性 男性
年龄(年) 68 33 67 36 64
Pancreatic diseases Pancreatic cancer Pancreatitis Pancreatic cancer Pancreatitis Pancreatic cancer
Locations of the pancreatic diseases Head, body, and tail Head Tail Body and tail Body and tail
Clinical presentation Melena Hematemesis and melena Blood in stomach Hematemesis and melena Hematemesis
Gastrointestinal bleeding at admission Yes Yes Yes Yes Yes
Comorbidities Left renal clear cell cancer
Left upper lung lobe metastatic cancer
Thyroid metastatic cancer
Left upper limb bone metastatic cancer		 Recurrent pancreatitis
Diabetes		 Hypertension Recurrent pancreatitis
Coronary heart disease
Hypertension		 Lacunar infarction
EGD Gastric varices Esophagogastric varices Gastric varices Gastric varices Gastric varices
Laboratory tests at admission
 WBC (109/L) 3.4 4.9 5.1 8.6 4.9
 GR (%) 63.4 75.8 66.8 66.5 79.2
加拿大皇家银行(1012/L) 2.63 4.27 3.05 4.00 4.01
 HB (g/L) 74 111 76 108 125
PLT (109/L) 78 71 209 205 78
 TBIL (μmol/L) 15.4 15.1 7.7 27.1 17.4
 DBIL (μmol/L) 9.2 3.7 2.2 7.8 4.4
 ALT (U/L) 116.02 14.55 12.59 8.09 23.33
 AST (U/L) 109.59 15.4 17.14 9.75 30.92
 AKP (U/L) 361.51 60.66 88.37 81.02 96.56
 GGT (U/L) 199.51 23.41 18.4 32.31 124
 AMY (U/L) 79.00 52.00 NA 92.00 145.00
 LIPA (U/L) 457.0 45.0 NA 394.0 52.0
Types of treatment Endoscopic variceal treatment
Pharmacological treatment		 Pharmacological treatment Distal pancreatectomy and splenectomy
Pharmacological treatment		 Pharmacological treatment Endoscopic spraying fluid film
Chemotherapy
Pharmacological treatment
Outcomes Died Died Survived Survived Survived
Abbreviations: EGD: esophagogastroduodenoscopy; WBC: white blood cell; GR%: neutrophil percentage; RBC: red blood cell; HB: hemoglobin concentration; PLT: platelet; TBIL: total bilirubin; DBIL: direct bilirubin; ALT: alanine aminotransaminase; AST: aspartate aminotransferase; AKP: alkaline phosphatase; GGT:γ-glutamyl transpeptidase: NA: not available; AMY: amylase; LIPA: lipase. The reference range of laboratory tests: WBC: ;GR%: 40-75%; RBC: ;HB: ;PLT: ;TBIL: 5.1-20.0 μmol/L; DBIL: 0-6.8 μmol/L; ALT: 7-50 U/L; AST: 13-40 U/L; AKP: 13-150 U/L; GGT: 7-60 U/L; AMY: 30-110 U/L; LIPA: 23-300 U/L.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy.Sign up hereas a reviewer to help fast-track new submissions.